BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31584190)

  • 1. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
    Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
    Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different menopausal hormone regimens and risk of breast cancer.
    Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
    Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
    Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
    Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
    Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
    Fournier A; Cairat M; Severi G; Gunter MJ; Rinaldi S; Dossus L
    J Natl Cancer Inst; 2023 Jun; 115(6):671-679. PubMed ID: 36809347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
    Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study.
    Baandrup L; Galanakis M; Hannibal CG; Dehlendorff C; Hertzum-Larsen R; Mørch LS; Kjaer SK
    Int J Cancer; 2022 Nov; 151(9):1512-1522. PubMed ID: 35716136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
    Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL;
    Gynecol Oncol; 2020 Sep; 158(3):702-709. PubMed ID: 32641237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and ovarian cancer.
    Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
    JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
    Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
    Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.
    Petrick JL; Joslin CE; Johnson CE; Camacho TF; Peres LC; Bandera EV; Barnard ME; Beeghly A; Bethea TN; Dempsey LF; Guertin K; Harris HR; Moorman PG; Myers ER; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Schildkraut JM; Rosenberg L
    Br J Cancer; 2023 Dec; 129(12):1956-1967. PubMed ID: 37865688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
    Hildebrand JS; Gapstur SM; Feigelson HS; Teras LR; Thun MJ; Patel AV
    Int J Cancer; 2010 Dec; 127(12):2928-35. PubMed ID: 21351271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
    Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
    Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
    Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
    Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
    Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P
    PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.